Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from ...

Novartis’ Kisqali (ribociclib) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat a ...

Its partner hormones are atrial natriuretic peptides ... These include the growth factor receptors, whose overactivations are common features in various cancers. "Our GC-A study should also ...

As treatment progresses however, a considerable proportion of tumors will acquire hormone ... steroid receptors, including ERα and ERβ, by non-steroidal factors including mitogens, growth ...

StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note issued to investors on Monday morning. The brokerage issued a sell rating on the ...

Athletes and fitness enthusiasts are always looking for advanced solutions to improve performance, recovery, and muscle growth.